Anticoagulant Drugs - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Anticoagulant Drugs - Global Top Players Market Share and Ranking 2025

Anticoagulant Drugs - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-04
Report Id: 2678599
Industry: Pharma & Healthcare
Report Page: 116
Chart: 118

PDF Download

Publication Date: 2025-11-04
Report Id: 2678599
Industry: Pharma & Healthcare
Report Page: 116
Chart: 118

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Anticoagulant Drugs Definition
1.2 Global Anticoagulant Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Anticoagulant Drugs Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Anticoagulant Drugs Market Size, 2020-2031
1.2.3 Global Anticoagulant Drugs Average Selling Price (ASP), 2020-2031
1.3 China Anticoagulant Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Anticoagulant Drugs Market Size, 2020-2031
1.3.2 By Sales Quantity, China Anticoagulant Drugs Market Size, 2020-2031
1.3.3 China Anticoagulant Drugs Average Selling Price (ASP), 2020-2031
1.4 Share of China Anticoagulant Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Anticoagulant Drugs Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Anticoagulant Drugs Market Share in Global, 2020-2031
1.4.3 Anticoagulant Drugs Market Size: China VS Global, 2020-2031
1.5 Anticoagulant Drugs Market Dynamics
1.5.1 Anticoagulant Drugs Market Drivers
1.5.2 Anticoagulant Drugs Market Restraints
1.5.3 Anticoagulant Drugs Industry Trends
1.5.4 Anticoagulant Drugs Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Anticoagulant Drugs, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Anticoagulant Drugs, Global Market Share by Company, 2020-2025
2.3 Anticoagulant Drugs Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Anticoagulant Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Anticoagulant Drugs Concentration Ratio
2.6 Global Anticoagulant Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Anticoagulant Drugs Manufacturers Product Type
2.8 Head Office and Anticoagulant Drugs Production Site of Key Manufacturer
2.9 Anticoagulant Drugs Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Anticoagulant Drugs, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Anticoagulant Drugs, China Market Share by Company, 2020-2025
3.3 China Anticoagulant Drugs Anticoagulant Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Anticoagulant Drugs Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Anticoagulant Drugs Capacity by Region
4.3 Global Anticoagulant Drugs Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Anticoagulant Drugs Production by Region, 2020-2031
4.5 Global Anticoagulant Drugs Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Anticoagulant Drugs Industry Chain
5.2 Anticoagulant Drugs Upstream Analysis
5.2.1 Anticoagulant Drugs Core Raw Materials
5.2.2 Main Manufacturers of Anticoagulant Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anticoagulant Drugs Production Mode
5.6 Anticoagulant Drugs Procurement Model
5.7 Anticoagulant Drugs Industry Sales Model and Sales Channels
5.7.1 Anticoagulant Drugs Sales Model
5.7.2 Anticoagulant Drugs Typical Distributors

6 Sights by Type
6.1 Anticoagulant Drugs Classification by Type
6.1.1 NOACs
6.1.2 Heparin
6.1.3 Warfarin
6.1.4 Others
6.2 by Type, Global Anticoagulant Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Anticoagulant Drugs Consumption Value, 2020-2031
6.4 by Type, Global Anticoagulant Drugs Sales Quantity, 2020-2031
6.5 by Type, Global Anticoagulant Drugs Average Selling Price (ASP), 2020-2031

7 Sights by Clinical Indication
7.1 Anticoagulant Drugs Classification by Clinical Indication
7.1.1 Atrial Fibrillation–Related Stroke Prevention
7.1.2 Venous Thromboembolism
7.1.3 Deep Vein Thrombosis
7.1.4 Postoperative or Trauma-related Thrombosis Prevention
7.1.5 Other
7.2 by Clinical Indication, Global Anticoagulant Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Clinical Indication, Global Anticoagulant Drugs Consumption Value, 2020-2031
7.4 by Clinical Indication, Global Anticoagulant Drugs Sales Quantity, 2020-2031
7.5 by Clinical Indication, Global Anticoagulant Drugs Average Selling Price (ASP), 2020-2031

8 Sights by Formulation Type
8.1 Anticoagulant Drugs Classification by Formulation Type
8.1.1 Oral Formulations
8.1.2 Injectable Formulations
8.2 by Formulation Type, Global Anticoagulant Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Formulation Type, Global Anticoagulant Drugs Consumption Value, 2020-2031
8.4 by Formulation Type, Global Anticoagulant Drugs Sales Quantity, 2020-2031
8.5 by Formulation Type, Global Anticoagulant Drugs Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Anticoagulant Drugs Segment by Application
9.1.1 Hospital
9.1.2 Pharmacy
9.1.3 Others
9.2 by Application, Global Anticoagulant Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Anticoagulant Drugs Consumption Value, 2020-2031
9.4 by Application, Global Anticoagulant Drugs Sales Quantity, 2020-2031
9.5 by Application, Global Anticoagulant Drugs Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Anticoagulant Drugs Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Anticoagulant Drugs Consumption Value, 2020-2031
10.3 By Region, Global Anticoagulant Drugs Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Anticoagulant Drugs Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Anticoagulant Drugs Market Size Market Share
10.5 Europe
10.5.1 Europe Anticoagulant Drugs Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Anticoagulant Drugs Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Anticoagulant Drugs Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Anticoagulant Drugs Market Size Market Share
10.7 South America
10.7.1 South America Anticoagulant Drugs Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Anticoagulant Drugs Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Anticoagulant Drugs Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Anticoagulant Drugs Consumption Value, 2020-2031
11.3 By Country, Global Anticoagulant Drugs Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Anticoagulant Drugs Market Size, 2020-2031
11.4.2 by Type, United States Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Anticoagulant Drugs Market Size, 2020-2031
11.5.2 by Type, Europe Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Anticoagulant Drugs Market Size, 2020-2031
11.6.2 by Type, China Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Anticoagulant Drugs Market Size, 2020-2031
11.7.2 by Type, Japan Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Anticoagulant Drugs Market Size, 2020-2031
11.8.2 by Type, South Korea Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Anticoagulant Drugs Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Anticoagulant Drugs Market Size, 2020-2031
11.10.2 by Type, India Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Anticoagulant Drugs Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Anticoagulant Drugs Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
12.1.2 Bristol-Myers Squibb Anticoagulant Drugs Models, Specifications, and Application
12.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Bristol-Myers Squibb Company Profile and Main Business
12.1.5 Bristol-Myers Squibb Recent Developments
12.2 Bayer
12.2.1 Bayer Company Information, Head Office, Market Area, and Industry Position
12.2.2 Bayer Anticoagulant Drugs Models, Specifications, and Application
12.2.3 Bayer Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Bayer Company Profile and Main Business
12.2.5 Bayer Recent Developments
12.3 Pfizer
12.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
12.3.2 Pfizer Anticoagulant Drugs Models, Specifications, and Application
12.3.3 Pfizer Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Pfizer Company Profile and Main Business
12.3.5 Pfizer Recent Developments
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
12.4.2 Johnson & Johnson Anticoagulant Drugs Models, Specifications, and Application
12.4.3 Johnson & Johnson Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Johnson & Johnson Company Profile and Main Business
12.4.5 Johnson & Johnson Recent Developments
12.5 Sanofi
12.5.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
12.5.2 Sanofi Anticoagulant Drugs Models, Specifications, and Application
12.5.3 Sanofi Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Sanofi Company Profile and Main Business
12.5.5 Sanofi Recent Developments
12.6 Boehringer Ingelheim
12.6.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
12.6.2 Boehringer Ingelheim Anticoagulant Drugs Models, Specifications, and Application
12.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Boehringer Ingelheim Company Profile and Main Business
12.6.5 Boehringer Ingelheim Recent Developments
12.7 Daiichi Sankyo
12.7.1 Daiichi Sankyo Company Information, Head Office, Market Area, and Industry Position
12.7.2 Daiichi Sankyo Anticoagulant Drugs Models, Specifications, and Application
12.7.3 Daiichi Sankyo Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Daiichi Sankyo Company Profile and Main Business
12.7.5 Daiichi Sankyo Recent Developments
12.8 Eisai Co Ltd
12.8.1 Eisai Co Ltd Company Information, Head Office, Market Area, and Industry Position
12.8.2 Eisai Co Ltd Anticoagulant Drugs Models, Specifications, and Application
12.8.3 Eisai Co Ltd Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Eisai Co Ltd Company Profile and Main Business
12.8.5 Eisai Co Ltd Recent Developments
12.9 Sun Pharmaceutical
12.9.1 Sun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
12.9.2 Sun Pharmaceutical Anticoagulant Drugs Models, Specifications, and Application
12.9.3 Sun Pharmaceutical Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 Sun Pharmaceutical Company Profile and Main Business
12.9.5 Sun Pharmaceutical Recent Developments
12.10 Teva
12.10.1 Teva Company Information, Head Office, Market Area, and Industry Position
12.10.2 Teva Anticoagulant Drugs Models, Specifications, and Application
12.10.3 Teva Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 Teva Company Profile and Main Business
12.10.5 Teva Recent Developments
12.11 Fresenius
12.11.1 Fresenius Company Information, Head Office, Market Area, and Industry Position
12.11.2 Fresenius Anticoagulant Drugs Models, Specifications, and Application
12.11.3 Fresenius Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.11.4 Fresenius Company Profile and Main Business
12.11.5 Fresenius Recent Developments
12.12 Jingzhou Pharma
12.12.1 Jingzhou Pharma Company Information, Head Office, Market Area, and Industry Position
12.12.2 Jingzhou Pharma Anticoagulant Drugs Models, Specifications, and Application
12.12.3 Jingzhou Pharma Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.12.4 Jingzhou Pharma Company Profile and Main Business
12.12.5 Jingzhou Pharma Recent Developments
12.13 Changzhou Qianhong
12.13.1 Changzhou Qianhong Company Information, Head Office, Market Area, and Industry Position
12.13.2 Changzhou Qianhong Anticoagulant Drugs Models, Specifications, and Application
12.13.3 Changzhou Qianhong Anticoagulant Drugs Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.13.4 Changzhou Qianhong Company Profile and Main Business
12.13.5 Changzhou Qianhong Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Anticoagulant Drugs should grow from US$ 34230 million in 2024 to US$ 46510 million by 2031, with a CAGR of 4.5% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Anticoagulant Drugs

According to YH Research, the global market for Anticoagulant Drugs should grow from US$ 34230 million in 2024 to US$ 46510 million by 2031, with a CAGR of 4.5% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Anticoagulant drugs are agents that inhibit the activity of clotting factors, thereby delaying or preventing the formation of blood clots. They are primarily used for the prevention and treatment of venous thromboembolism, atrial fibrillation–related stroke, deep vein thrombosis, and pulmonary embolism. These medications regulate the coagulation cascade through various mechanisms, including vitamin K antagonists (e.g., warfarin), heparin-based agents, direct thrombin inhibitors (e.g., dabigatran), and factor Xa inhibitors (e.g., rivaroxaban, apixaban). With the growing prevalence of cardiovascular diseases and an aging population, anticoagulant drugs have become an essential component of modern thrombosis management and preventive medicine.In 2024, global Anticoagulant drugs production reached approximately 189.35 m units, with an average global market price of around US$ 170 perunit.The average gross profit margin of this product is 75%.

The growth of the anticoagulant drugs market is driven by the rising global incidence of thromboembolic disorders and increased awareness of their management. The expanding elderly population, prevalence of obesity, and metabolic syndromes have significantly increased the demand for chronic cardiovascular anticoagulation therapy. Moreover, growing emphasis on patient compliance and safety in both hospitals and primary care settings has accelerated the adoption of direct oral anticoagulants (DOACs). The advancement of biotechnology and precision medicine is also fostering the development of individualized anticoagulation regimens, innovative formulations, and combination therapies, further expanding the therapeutic scope of anticoagulants.

The clinical management of anticoagulant drugs faces significant challenges, primarily related to bleeding risk, drug interactions, and monitoring requirements. Traditional agents such as warfarin require frequent INR monitoring and are affected by dietary factors, leading to poor compliance. Although new oral anticoagulants simplify treatment, their high cost and limited reversibility restrict widespread use. In developing regions, inadequate treatment infrastructure, limited physician training, and low drug accessibility further hinder market penetration. Additionally, strict patent protection and regulatory barriers heighten entry challenges, concentrating competition among a few multinational pharmaceutical giants.

Downstream demand for anticoagulant drugs is becoming more diversified and scenario-driven, evolving from traditional in-hospital acute treatment to long-term outpatient and post-surgical prophylaxis. Strong growth is observed in indications such as atrial fibrillation, venous thrombosis, and cancer-associated thrombosis. The younger patient population and widespread adoption of digital health platforms are fostering remote monitoring and smart medication management as emerging growth areas. Improved insurance coverage and patient education are also enhancing compliance and treatment continuity, accelerating the market’s shift from “acute intervention” to “chronic management.”
The upstream raw materials for anticoagulant drugs primarily include sodium heparin, intermediates for vitamin K antagonists, synthetic peptide-based APIs, and key heterocyclic compounds. Manufacturing demands stringent control over purity, polymorphism, and impurities, with particular emphasis on traceability and quality assurance of animal-derived heparin. As global API supply chains become more consolidated, China and India dominate small-molecule intermediate production. Moving forward, green synthesis technologies, biotechnological fermentation routes, and localized supply chains will play critical roles in addressing price volatility and rising quality standards in upstream operations.

This report studies and analyses global Anticoagulant Drugs status and future trends, helps the client to determine the Anticoagulant Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Anticoagulant Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Anticoagulant Drugs market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (K Units)
(2) Global Anticoagulant Drugs sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(3) China Anticoagulant Drugs sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (K Units)
(4) Global Anticoagulant Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Anticoagulant Drugs key producing regions, capacity, production, and year over year growth
(6) Anticoagulant Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Eisai Co Ltd
Sun Pharmaceutical
Teva
Fresenius
Jingzhou Pharma
Changzhou Qianhong

Market segment by Type, covers
NOACs
Heparin
Warfarin
Others

Market segment by Clinical Indication, covers
Atrial Fibrillation–Related Stroke Prevention
Venous Thromboembolism
Deep Vein Thrombosis
Postoperative or Trauma-related Thrombosis Prevention
Other

Market segment by Formulation Type, covers
Oral Formulations
Injectable Formulations

Market segment by Application, can be divided into
Hospital
Pharmacy
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Anticoagulant Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Anticoagulant Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Anticoagulant Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Anticoagulant Drugs, percent & CAGR, 2020-2031
Chapter 5: Anticoagulant Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.